| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/11/2014 | CN103845285A Sodium new houttuyfonate intravenous fluid and preparation method thereof |
| 06/11/2014 | CN103845283A Spectinomycin hydrochloride solution and preparation method thereof |
| 06/11/2014 | CN103845282A Dinitolmide solution and preparation method thereof |
| 06/11/2014 | CN103845281A Gentamicin sulphate solution and preparation method thereof |
| 06/11/2014 | CN103843823A Preparation method for cellulose ether nano-silver antibacterial agent |
| 06/11/2014 | CN103230364B Preparation method of ceftiofur acid long-acting injection |
| 06/11/2014 | CN103142512B High-quality composition containing oxaliplatin and preparation method of composition |
| 06/11/2014 | CN103110935B Hydrolyzed collagen liposome for local skin and preparation method thereof |
| 06/11/2014 | CN103096882B Transdermal drug delivery system containing donepezil |
| 06/11/2014 | CN103054814B Preparation method for polysaccharide microspheres based on medicine cross-linking |
| 06/11/2014 | CN103045576B PolyHb-rPA complex, preparation method and application of PolyHb-rPA complex |
| 06/11/2014 | CN103028121B miR-21 compound of target microglial cell and preparation method and application of miR-21 compound |
| 06/11/2014 | CN102988359B Compound amino acid injection (18AA-I) composition |
| 06/11/2014 | CN102921002B Japanese encephalitis vaccine cryoprotectant |
| 06/11/2014 | CN102920665B Colon-targeted zinc oxide pellet and preparation method thereof |
| 06/11/2014 | CN102895216B Anti-cancer medicament silicon plastid microcapsule and preparation method thereof |
| 06/11/2014 | CN102838671B Growth hormone with site-specific mutagenesis and site-specific decoration, preparation method and applications of growth hormone |
| 06/11/2014 | CN102836129B Cefprozil dry suspension and preparation method thereof |
| 06/11/2014 | CN102824643B Starch-based hydrogel carrier material for controlling slow-release, and preparation method and application thereof |
| 06/11/2014 | CN102727444B Entecavir solid dispersion, pharmaceutical composition, method for preparing entecavir solid dispersion and pharmaceutical application of entecavir solid dispersion |
| 06/11/2014 | CN102702453B pH-responsive 6-arm star block copolymer and preparation method and application thereof |
| 06/11/2014 | CN102625715B Seamless alginate capsules |
| 06/11/2014 | CN102617851B Method for preparing poly (L-glutamic acid) with controllable molecular weight |
| 06/11/2014 | CN102600013B Medical flocking hemostasis material, preparation thereof and application |
| 06/11/2014 | CN102596251B High strength seamless alginate capsules |
| 06/11/2014 | CN102579365B Risperidone microsphere preparation and preparation method thereof |
| 06/11/2014 | CN102552234B Meclofenoxate hydrochloride medicinal composition and method for preparing freeze-drying powder injection of meclofenoxate hydrochloride medicinal composition |
| 06/11/2014 | CN102525880B Aprepitant solid dispersion composition |
| 06/11/2014 | CN102497883B Alginate oligomers for use in overcoming multidrug resistance in bacteria |
| 06/11/2014 | CN102497856B Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 06/11/2014 | CN102489231B Preparation method of hydroxy apatite / polylactic acid / chitosan composite microballoon |
| 06/11/2014 | CN102458474B Treatment of acinetobacter with alginate oligomers and antibiotics |
| 06/11/2014 | CN102357077B Protein nanometer particle for wrapping slightly soluble medicines and preparation method thereof |
| 06/11/2014 | CN102357076B Preparation method of protein nanoparticles coating insoluble drug |
| 06/11/2014 | CN102204940B Evening primrose oil microcapsule and pulverization method |
| 06/11/2014 | CN102188385B Sustained-release pellets containing nebivolol as active component and preparation method thereof |
| 06/11/2014 | CN102151252B Glipizide osmotic pump type controlled release tablet |
| 06/11/2014 | CN101925356B Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation |
| 06/11/2014 | CN101897981B Method for inhibiting proliferation and inducing apoptosis of cancer cells and use thereof |
| 06/11/2014 | CN101862620B Emulsifier containing glycerine-modified organopolysiloxanes |
| 06/11/2014 | CN101804048B Antiparasitic composition for animal |
| 06/11/2014 | CN101692894B Use of multi-layer pigments in the food and pharmaceutical industry |
| 06/10/2014 | US8748425 Combination of brimonidine and timolol for topical ophthalmic use |
| 06/10/2014 | US8748380 Albumin variants |
| 06/10/2014 | US8748371 Nuclear targeting sequences |
| 06/10/2014 | US8747923 Methods for improving health in canines |
| 06/10/2014 | US8747922 Methods and compositions for increasing sex steroids and growth hormones |
| 06/10/2014 | US8747921 Methods for improving health in humans |
| 06/10/2014 | US8747912 Drug delivery system |
| 06/10/2014 | US8747899 Injectable in situ self-forming mineral-polymer hybrid composition and uses thereof |
| 06/10/2014 | US8747896 Mucosal bioadhesive slow release carrier for delivering active principles |
| 06/10/2014 | US8747892 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 06/10/2014 | US8747889 Transdermal analgesic systems with reduced abuse potential |
| 06/10/2014 | US8747870 Polymeric compositions and methods of making and using thereof |
| 06/10/2014 | US8747869 Lipid vesicle compositions and methods of use |
| 06/10/2014 | US8747863 Vaccine for shigella |
| 06/10/2014 | US8747857 Calicheamicin derivative-carrier conjugates |
| 06/10/2014 | US8747832 Biodegradable polyanhydrides with natural bioactive molecules |
| 06/10/2014 | US8747824 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 06/10/2014 | US8747817 System and method of complementary day/night children's skin cream compositions |
| 06/10/2014 | CA2656966C A topical analgesic composition |
| 06/10/2014 | CA2647982C Solid pharmaceutical preparation containing tramadol |
| 06/10/2014 | CA2612090C Tablet containing hardly soluble active ingredient |
| 06/10/2014 | CA2456864C Adjuvant composition for mucosal and injection delivered vaccines |
| 06/10/2014 | CA2441287C Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 06/10/2014 | CA2361268C A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| 06/10/2014 | CA2287451C Topical use of probiotic bacillus spores to prevent or control microbial infections |
| 06/05/2014 | WO2014085668A1 Anticonvulsant activity of steroids |
| 06/05/2014 | WO2014085471A1 Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation |
| 06/05/2014 | WO2014085297A1 Multifunctional bacteriophage for delivery of therapeutic agents and imaging reagents |
| 06/05/2014 | WO2014084736A1 A pharmaceutical composition containing vitamin b12 |
| 06/05/2014 | WO2014084670A1 Composition of external application to skin |
| 06/05/2014 | WO2014084657A1 Inorganic powder coated with biocompatible polymer, and cosmetic composition comprising same |
| 06/05/2014 | WO2014084630A1 Chromic microcapsule comprising colorant core and pressure sensitive destructible wall layer, and preparation method therefor |
| 06/05/2014 | WO2014084629A1 Chromic microcapsule comprising core seed and pressure sensitive destructible wall layer, and preparation method therefor |
| 06/05/2014 | WO2014084572A1 Catechin bioavailability enhancer comprising cyclodextrin |
| 06/05/2014 | WO2014084568A1 Topical gel composition containing dexibuprofen emulsion with enhanced permeability |
| 06/05/2014 | WO2014084567A1 Silk hydrogel composition and silk hydrogel mask |
| 06/05/2014 | WO2014084530A1 Biodegradable microbead comprising anionic polymer for improving adsorptive power to anticancer drugs, and method for preparing same |
| 06/05/2014 | WO2014084508A1 Composition for stabilizing fusion protein in which protein and fc domain are fused |
| 06/05/2014 | WO2014084423A1 Pressure sensitive destructible microcapsule containing scrubbing agents, preparation method therefor, and use therefor |
| 06/05/2014 | WO2014084421A1 Bile acid oligomer conjugate for novel vesicular transport and use thereof |
| 06/05/2014 | WO2014084401A1 Medical patch |
| 06/05/2014 | WO2014084378A1 Anticancer drug comprising cyclic rgd sequence-containing peptide |
| 06/05/2014 | WO2014084311A1 Ropinirole-containing adhesive patch |
| 06/05/2014 | WO2014084110A1 Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same |
| 06/05/2014 | WO2014083613A1 Peritoneal dialysis fluid |
| 06/05/2014 | WO2014083612A1 Peritoneal dialysis fluid |
| 06/05/2014 | WO2014083505A1 Methods for making conjugates from disulfide-containing proteins |
| 06/05/2014 | WO2014083233A1 Microparticles with egf, method of preparation and use |
| 06/05/2014 | WO2014083071A1 Injectable liquid formulation of the combination of tramadol and paracetamol |
| 06/05/2014 | WO2014083004A1 Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targeted mhc class i comprising multi-function proteins |
| 06/05/2014 | WO2014082724A1 Aqueous oral solutions of steroid hormones and hydroxypropyl-beta-cyclodextrin with optimised bioavailability |
| 06/05/2014 | WO2014082651A1 Novel method for improving the bioavailability of low aqueous solubility drugs |
| 06/05/2014 | WO2014082609A1 C6-c18-acylated derivative of hyaluronic acid, method of preparation thereof, nanomicellar composition on its basis, method of preparation thereof and method of preparation stabilized nanomicellar composition, and use thereof |
| 06/05/2014 | WO2014082608A1 Photoreactive derivative of hyaluronic acid, method of preparation thereof, 3d-crosslinked derivative of hyaluronic acid, method of preparation and use thereof |
| 06/05/2014 | WO2014082569A1 Use of artemether in preparation of drug for treating leukemia |
| 06/05/2014 | WO2014082184A1 Targeted iduronate-2-sulfatase compounds |
| 06/05/2014 | WO2014082163A1 Tox inhibition for the treatment of cancer |
| 06/05/2014 | WO2014066898A9 A layer-by-layer approach to co-deliver dna and sirna via aunps: a potential platform for modifying release kinetics |